Cite
FRAX486, a PAK inhibitor, overcomes ABCB1-mediated multidrug resistance in breast cancer cells
MLA
Meng Zhang, et al. “FRAX486, a PAK Inhibitor, Overcomes ABCB1-Mediated Multidrug Resistance in Breast Cancer Cells.” Brazilian Journal of Medical and Biological Research, vol. 57, July 2024. EBSCOhost, https://doi.org/10.1590/1414-431x2024e13357.
APA
Meng Zhang, Xiaoqi Zeng, Meiling She, Xingduo Dong, Jun Chen, Qingquan Xiong, Guobin Qiu, Shuyi Yang, Xiangqi Li, & Guanghui Ren. (2024). FRAX486, a PAK inhibitor, overcomes ABCB1-mediated multidrug resistance in breast cancer cells. Brazilian Journal of Medical and Biological Research, 57. https://doi.org/10.1590/1414-431x2024e13357
Chicago
Meng Zhang, Xiaoqi Zeng, Meiling She, Xingduo Dong, Jun Chen, Qingquan Xiong, Guobin Qiu, Shuyi Yang, Xiangqi Li, and Guanghui Ren. 2024. “FRAX486, a PAK Inhibitor, Overcomes ABCB1-Mediated Multidrug Resistance in Breast Cancer Cells.” Brazilian Journal of Medical and Biological Research 57 (July). doi:10.1590/1414-431x2024e13357.